Escape the Drug Pricing Maze #12 – Making Biosimilars and Gene Therapies More Affordable and Accessible: 3 Keys to Reform Drug Pricing System, Part 2

Escape the Drug Pricing Maze #12 – Making Biosimilars and Gene Therapies More Affordable and Accessible: 3 Keys to Reform Drug Pricing System, Part 2

As they approach the end of the Drug Pricing Maze, the Professor and Pete explore reforms to fix a broken system and encourage the use of cheaper biosimilars that can help patients and the health care system save big. They also learn what can be done to make very expensive gene therapies that provide a lot of value for patients more affordable and accessible.